Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Levoleucovorin Calcium Patent Expiration

Levoleucovorin Calcium was first introduced by Acrotech Biopharma Inc in its drug Fusilev on Mar 7, 2008. Another drug containing Levoleucovorin Calcium is Levoleucovorin Calcium. 11 different companies have introduced drugs containing Levoleucovorin Calcium.


Levoleucovorin Calcium Patents

Given below is the list of patents protecting Levoleucovorin Calcium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Fusilev US6500829 Substantially pure diastereoisomers of tetrahydrofolate derivatives Mar 07, 2022

(Expired)

 Acrotech Biopharma



Levoleucovorin Calcium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Levoleucovorin Calcium Generic API Manufacturers

Several generic applications have been filed for Levoleucovorin Calcium. The first generic version for Levoleucovorin Calcium was by Sandoz Inc and was approved on Mar 9, 2015. And the latest generic version is by Hainan Poly Pharmaceutical Co Ltd and was approved on May 22, 2023.

Given below is the list of companies who have filed for Levoleucovorin Calcium generic, along with the locations of their manufacturing plants worldwide.